RILONACEPT

RILONACEPT was reported 1157 times

RILONACEPT is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PERICARDIAL PERFORATION 1 0.3333
1 ANGIOTENSIN II RECEPTOR TYPE 1 ANTIBODY POSITIVE 1 0.2500
2 AUTOIMMUNE APLASTIC ANAEMIA 1 0.0714
3 FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1 0.0556
4 MYOPIC CHORIORETINAL DEGENERATION 1 0.0455
5 VENTRICULAR SEPTAL DEFECT ACQUIRED 1 0.0417
6 PERIPROSTHETIC JOINT INFECTION 1 0.0417
7 MUCKLE-WELLS SYNDROME 2 0.0408
8 PARATHYROID CYST 1 0.0385
9 MUSCLE FLAP OPERATION 1 0.0370
10 VIRAL TITRE DECREASED 1 0.0278
11 PERICARDITIS URAEMIC 1 0.0204
12 CRYOPYRIN ASSOCIATED PERIODIC SYNDROME 4 0.0204
13 COMMUNITY ACQUIRED INFECTION 1 0.0179
14 TRANSFERRIN INCREASED 1 0.0179
15 INJECTION SITE VASCULITIS 1 0.0175
16 MATERNAL EXPOSURE VIA PARTNER DURING PREGNANCY 1 0.0156
17 CARDIAC THERAPEUTIC PROCEDURE 1 0.0147
18 HYPERTROPHIC OSTEOARTHROPATHY 1 0.0147
19 PERICARDIAL FIBROSIS 2 0.0144
20 PERICARDITIS CONSTRICTIVE 6 0.0142
21 MYOFASCITIS 1 0.0120
22 HAEMATOTYMPANUM 1 0.0118
23 PERICARDIAL EXCISION 1 0.0104
24 AVERSION 3 0.0104
25 FAMILIAL MEDITERRANEAN FEVER 2 0.0102
26 POSTOPERATIVE RESPIRATORY FAILURE 1 0.0096
27 LARYNGITIS VIRAL 1 0.0094
28 MALIGNANT MEDIASTINAL NEOPLASM 1 0.0091
29 INJECTION SITE EXFOLIATION 6 0.0090
30 NAIL BED TENDERNESS 1 0.0088
31 GINGIVAL HYPERPLASIA 5 0.0083
32 PRODUCT GEL FORMATION 1 0.0082
33 TROPONIN ABNORMAL 1 0.0081
34 INADVERTENT INJECTION AIR BUBBLE 1 0.0079
35 ACTINOMYCES TEST POSITIVE 1 0.0078
36 LABORATORY TEST 1 0.0074
37 ABSCESS STERILE 1 0.0068
38 SERUM AMYLOID A PROTEIN INCREASED 1 0.0065
39 JUVENILE ARTHRITIS 2 0.0061
40 PULMONARY ARTERY DILATATION 2 0.0058
41 STEROID DEPENDENCE 5 0.0057
42 INJECTION SITE EROSION 2 0.0057
43 RIGHT VENTRICULAR HYPERTROPHY 5 0.0055
44 PERICARDITIS 90 0.0054
45 PLEURAL ADHESION 1 0.0050
46 CARDIAC NEOPLASM UNSPECIFIED 1 0.0050
47 UROGENITAL DISORDER 1 0.0050
48 OCULAR ROSACEA 1 0.0049
49 PNEUMOCONIOSIS 1 0.0048
50 SKIN PRESSURE MARK 1 0.0047
51 MUSCLE OEDEMA 1 0.0046
52 NEURALGIC AMYOTROPHY 1 0.0044
53 NECROTISING SOFT TISSUE INFECTION 1 0.0043
54 ALBUMIN GLOBULIN RATIO DECREASED 1 0.0043
55 INJECTION SITE PHLEBITIS 1 0.0043
56 APPENDICEAL ABSCESS 1 0.0041
57 SLEEVE GASTRECTOMY 1 0.0041
58 MYCOBACTERIUM CHELONAE INFECTION 3 0.0041
59 NIPPLE SWELLING 1 0.0040
60 HIRSUTISM 5 0.0038
61 THYROID HORMONES DECREASED 3 0.0037
62 VICTIM OF ABUSE 1 0.0037
63 HYPERTENSIVE CARDIOMYOPATHY 1 0.0036
64 PULMONARY VALVE INCOMPETENCE 5 0.0034
65 METASTASES TO HEART 1 0.0033
66 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 3 0.0032
67 MALABSORPTION FROM INJECTION SITE 1 0.0032
68 INJECTION SITE HYPERTROPHY 1 0.0031
69 DISCONTINUED PRODUCT ADMINISTERED 1 0.0030
70 BENIGN HYDATIDIFORM MOLE 1 0.0030
71 ACUTE STRESS DISORDER 1 0.0030
72 PULMONARY VENO-OCCLUSIVE DISEASE 2 0.0029
73 GASTROINTESTINAL MICROORGANISM OVERGROWTH 1 0.0028
74 INFECTED DERMAL CYST 1 0.0028
75 INADEQUATE ASEPTIC TECHNIQUE IN USE OF PRODUCT 1 0.0028
76 GLOBULINS INCREASED 1 0.0027
77 ECLAMPSIA 1 0.0027
78 INJECTION SITE CELLULITIS 5 0.0027
79 PITYRIASIS ROSEA 1 0.0027
80 ANISOCORIA 1 0.0026
81 INJECTION SITE INFLAMMATION 13 0.0026
82 KETONURIA 2 0.0025
83 CLUBBING 1 0.0025
84 SOCIAL PROBLEM 10 0.0024
85 PERIOSTITIS 1 0.0023
86 HEART VALVE OPERATION 1 0.0023
87 PRODUCT RECONSTITUTION QUALITY ISSUE 2 0.0022
88 INJECTION SITE DRYNESS 2 0.0022
89 INJECTION SITE RASH 67 0.0022
90 SYMPTOM RECURRENCE 13 0.0022
91 URINARY TRACT DISCOMFORT 1 0.0022
92 ANGIOSARCOMA 1 0.0022
93 EATING DISORDER SYMPTOM 1 0.0022
94 HELPLESSNESS 1 0.0021
95 TYPE V HYPERLIPIDAEMIA 1 0.0021
96 IMMUNODEFICIENCY COMMON VARIABLE 1 0.0020
97 BREAST ABSCESS 2 0.0020
98 BLOOD GASES ABNORMAL 1 0.0019
99 LEFT ATRIAL ENLARGEMENT 1 0.0019
100 INAPPROPRIATE SCHEDULE OF PRODUCT DISCONTINUATION 1 0.0019
101 INTERLEUKIN LEVEL INCREASED 1 0.0018
102 PRODUCT CLOSURE ISSUE 1 0.0018
103 EXPOSURE TO SARS-COV-2 3 0.0018
104 EUSTACHIAN TUBE DYSFUNCTION 1 0.0017
105 DOSE CALCULATION ERROR 1 0.0017
106 ALVEOLAR PROTEINOSIS 1 0.0017
107 NEUROPSYCHOLOGICAL SYMPTOMS 1 0.0017
108 SUPERIOR VENA CAVA SYNDROME 1 0.0017
109 CORTISOL INCREASED 1 0.0016
110 ACTIVITIES OF DAILY LIVING DECREASED 1 0.0016
111 GLIOMA 1 0.0016
112 STAPHYLOCOCCAL ABSCESS 1 0.0016
113 C-REACTIVE PROTEIN DECREASED 1 0.0015
114 EMPYEMA 3 0.0015
115 BRONCHITIS VIRAL 1 0.0015
116 PLEURAL THICKENING 1 0.0015
117 ECHOCARDIOGRAM ABNORMAL 2 0.0014
118 INJECTION SITE SCAR 4 0.0014
119 GASTRITIS HAEMORRHAGIC 2 0.0013
120 HEART SOUNDS ABNORMAL 1 0.0013
121 PERFORATED ULCER 1 0.0013
122 ENTEROVESICAL FISTULA 1 0.0013
123 INJECTION SITE WARMTH 27 0.0013
124 INJECTION SITE PARAESTHESIA 2 0.0013
125 INJECTION SITE DISCHARGE 7 0.0013
126 CREATINE KINASE INCREASED 1 0.0013
127 EXPOSURE VIA BODY FLUID 1 0.0013
128 INJECTION SITE DISCOMFORT 13 0.0012
129 ENTEROCOCCAL SEPSIS 1 0.0012
130 POLYCYTHAEMIA VERA 1 0.0012
131 INJECTION RELATED REACTION 2 0.0012
132 PRODUCT SOLUBILITY ABNORMAL 6 0.0012
133 TYMPANIC MEMBRANE PERFORATION 2 0.0012
134 PRODUCT TEMPERATURE EXCURSION ISSUE 6 0.0012
135 LUNG HYPERINFLATION 1 0.0012
136 TONGUE PRURITUS 1 0.0012
137 ENDOCRINE OPHTHALMOPATHY 1 0.0012
138 WEIGHT BEARING DIFFICULTY 3 0.0011
139 INJECTION SITE IRRITATION 14 0.0011
140 INJECTION SITE ERYTHEMA 134 0.0011
141 LYMPH NODE PAIN 2 0.0011
142 THERAPEUTIC RESPONSE DELAYED 3 0.0011
143 INJECTION SITE MASS 39 0.0011
144 CORRECTIVE LENS USER 1 0.0010
145 LYMPHADENECTOMY 1 0.0010
146 SPINAL LAMINECTOMY 1 0.0010
147 INJECTION SITE PRURITUS 68 0.0010
148 HISTIOCYTOSIS HAEMATOPHAGIC 3 0.0010
149 ADMINISTRATION SITE EXTRAVASATION 1 0.0010
150 DILATED CARDIOMYOPATHY 1 0.0010
151 BENIGN BREAST NEOPLASM 1 0.0010
152 STEROID WITHDRAWAL SYNDROME 1 0.0010
153 SYSTOLIC DYSFUNCTION 1 0.0009
154 BLOOD SODIUM ABNORMAL 1 0.0009
155 PRODUCT PREPARATION ISSUE 6 0.0009
156 INFECTIOUS MONONUCLEOSIS 2 0.0009
157 PRODUCT LEAKAGE 5 0.0009
158 MENINGITIS ASEPTIC 4 0.0009
159 LYMPHOCYTE COUNT ABNORMAL 1 0.0009
160 HYPERSENSITIVITY PNEUMONITIS 1 0.0009
161 THERAPEUTIC PRODUCT EFFECT DELAYED 4 0.0009
162 HYPERTRANSAMINASAEMIA 6 0.0009
163 DILATATION ATRIAL 1 0.0009
164 INJECTION SITE REACTION 59 0.0009
165 COCCIDIOIDOMYCOSIS 1 0.0008
166 VARICELLA 2 0.0008
167 INJECTION SITE VESICLES 5 0.0008
168 MONOCYTE COUNT DECREASED 1 0.0008
169 INJECTION SITE URTICARIA 20 0.0008
170 STAPHYLOCOCCAL SKIN INFECTION 1 0.0008
171 PHARYNGEAL HAEMORRHAGE 1 0.0008
172 DRUG EFFECT LESS THAN EXPECTED 12 0.0008
173 CARDIAC DYSFUNCTION 3 0.0008
174 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 6 0.0008
175 BENIGN INTRACRANIAL HYPERTENSION 1 0.0008
176 PERIPHERAL SENSORIMOTOR NEUROPATHY 1 0.0008
177 PRODUCT COMPLAINT 20 0.0008
178 ENDOCRINE DISORDER 1 0.0008
179 GESTATIONAL HYPERTENSION 1 0.0008
180 GASTROENTERITIS NOROVIRUS 1 0.0008
181 EAR CONGESTION 2 0.0007
182 ANAPHYLACTOID REACTION 3 0.0007
183 STREPTOCOCCAL INFECTION 4 0.0007
184 MYELITIS TRANSVERSE 1 0.0007
185 INJECTION SITE INDURATION 9 0.0007
186 PERICARDIAL EFFUSION 16 0.0007
187 SEBORRHOEIC KERATOSIS 1 0.0007
188 LIQUID PRODUCT PHYSICAL ISSUE 5 0.0007
189 PLEURISY 4 0.0007
190 SKIN STRIAE 1 0.0007
191 INJECTION SITE SWELLING 50 0.0007
192 CHEST PAIN 120 0.0006
193 SUBSTANCE USE 1 0.0006
194 ELECTROCARDIOGRAM T WAVE ABNORMAL 1 0.0006
195 BACTERIAL VAGINOSIS 1 0.0006
196 INJECTION SITE HYPERSENSITIVITY 2 0.0006
197 INCORRECT DOSE ADMINISTERED BY PRODUCT 1 0.0006
198 COSTOCHONDRITIS 1 0.0006
199 OROPHARYNGEAL BLISTERING 1 0.0006
200 VASOPLEGIA SYNDROME 1 0.0006
201 INJECTION SITE INFECTION 2 0.0006
202 EDUCATIONAL PROBLEM 1 0.0006
203 SEIZURE LIKE PHENOMENA 1 0.0006
204 GLIOBLASTOMA 1 0.0006
205 AMYLOIDOSIS 1 0.0006
206 SERUM FERRITIN DECREASED 1 0.0006
207 TREATMENT DELAYED 1 0.0006
208 FEAR OF INJECTION 4 0.0006
209 PRODUCT SUPPLY ISSUE 4 0.0006
210 SUSPECTED PRODUCT QUALITY ISSUE 1 0.0005
211 METAMORPHOPSIA 1 0.0005
212 LOBAR PNEUMONIA 1 0.0005
213 DENTAL CARE 1 0.0005
214 WHITE BLOOD CELLS URINE POSITIVE 1 0.0005
215 LIP DISORDER 1 0.0005
216 PATIENT DISSATISFACTION WITH TREATMENT 1 0.0005
217 CONCOMITANT DISEASE PROGRESSION 1 0.0005
218 GENE MUTATION 1 0.0005
219 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 24 0.0005
220 EAR HAEMORRHAGE 1 0.0005
221 NIPPLE PAIN 1 0.0005
222 INJECTION SITE HAEMORRHAGE 39 0.0005
223 CHEST DISCOMFORT 50 0.0005
224 HYPERPARATHYROIDISM 1 0.0005
225 CHEST INJURY 1 0.0005
226 BODY TEMPERATURE FLUCTUATION 1 0.0005
227 EAR SWELLING 1 0.0005
228 EXOPHTHALMOS 1 0.0005
229 PRODUCT COMMUNICATION ISSUE 4 0.0005
230 GASTROINTESTINAL ULCER 1 0.0005
231 BACTERIAL TEST POSITIVE 1 0.0004
232 OCULAR DISCOMFORT 5 0.0004
233 FEAR OF DEATH 1 0.0004
234 IMMUNE THROMBOCYTOPENIA 2 0.0004
235 PANCREATITIS NECROTISING 1 0.0004
236 BREAKTHROUGH PAIN 1 0.0004
237 PRODUCT DISTRIBUTION ISSUE 4 0.0004
238 SKIN REACTION 6 0.0004
239 INGROWING NAIL 1 0.0004
240 COLITIS MICROSCOPIC 2 0.0004
241 CARDIAC TAMPONADE 2 0.0004
242 OXYGEN CONSUMPTION INCREASED 1 0.0004
243 LIMB OPERATION 2 0.0004
244 LYMPHADENITIS 1 0.0004
245 AUTOIMMUNE DISORDER 4 0.0004
246 INCORRECT DOSAGE ADMINISTERED 2 0.0004
247 JUVENILE IDIOPATHIC ARTHRITIS 1 0.0004
248 DERMAL CYST 1 0.0004
249 THERAPY CHANGE 4 0.0004
250 STAPHYLOCOCCAL SEPSIS 2 0.0004
251 HYPERVOLAEMIA 2 0.0004
252 INFLAMMATORY MARKER INCREASED 2 0.0004
253 SUFFOCATION FEELING 1 0.0004
254 INJECTION SITE DISCOLOURATION 5 0.0004
255 VENOOCCLUSIVE DISEASE 1 0.0004
256 DERMATOMYOSITIS 1 0.0004
257 APPENDICITIS PERFORATED 1 0.0004
258 PRODUCT PACKAGING DIFFICULT TO OPEN 1 0.0004
259 HYPERSENSITIVITY VASCULITIS 1 0.0004
260 SERUM FERRITIN INCREASED 2 0.0004
261 SARS-COV-2 TEST POSITIVE 5 0.0004
262 BLOOD DISORDER 3 0.0004
263 ABDOMINAL MASS 1 0.0004
264 SKIN DISCOMFORT 1 0.0004
265 UPPER RESPIRATORY TRACT INFECTION 17 0.0004
266 CYTOMEGALOVIRUS INFECTION 6 0.0004
267 EAR PAIN 7 0.0004
268 DRUG TOLERANCE DECREASED 1 0.0004
269 NEUTROPHIL COUNT ABNORMAL 1 0.0004
270 NECK MASS 1 0.0004
271 OXYGEN SATURATION ABNORMAL 1 0.0004
272 RESPIRATORY SYMPTOM 1 0.0004
273 PRODUCT DOSE OMISSION ISSUE 103 0.0003
274 UPPER RESPIRATORY TRACT CONGESTION 1 0.0003
275 ESCHERICHIA SEPSIS 1 0.0003
276 ABORTION 1 0.0003
277 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
278 WRONG PATIENT RECEIVED PRODUCT 1 0.0003
279 NEGATIVE THOUGHTS 1 0.0003
280 NECK INJURY 1 0.0003
281 CENTRAL VENOUS CATHETERISATION 1 0.0003
282 KERATITIS 1 0.0003
283 IRITIS 1 0.0003
284 INJECTION SITE BRUISING 26 0.0003
285 ECTOPIC PREGNANCY 1 0.0003
286 PORTAL HYPERTENSION 1 0.0003
287 FAMILY STRESS 1 0.0003
288 BLOOD BLISTER 1 0.0003
289 SWELLING OF EYELID 2 0.0003
290 BLEPHAROSPASM 2 0.0003
291 PRODUCT USE COMPLAINT 5 0.0003
292 BLADDER PAIN 1 0.0003
293 RESPIRATORY TRACT CONGESTION 5 0.0003
294 C-REACTIVE PROTEIN ABNORMAL 2 0.0003
295 CUSHINGOID 1 0.0003
296 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 8 0.0003
297 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
298 PHARYNGEAL SWELLING 3 0.0003
299 DEAFNESS NEUROSENSORY 1 0.0003
300 ORAL CANDIDIASIS 4 0.0003
301 ADVERSE REACTION 4 0.0003
302 PREGNANCY 6 0.0003
303 WOUND COMPLICATION 1 0.0003
304 REGURGITATION 1 0.0003
305 INTERNATIONAL NORMALISED RATIO ABNORMAL 1 0.0003
306 AORTIC STENOSIS 1 0.0003
307 INJECTION SITE PAIN 88 0.0003
308 ERYTHEMA NODOSUM 1 0.0003
309 FIBRIN D DIMER INCREASED 1 0.0003
310 APPENDICECTOMY 1 0.0003
311 PYODERMA GANGRENOSUM 1 0.0003
312 PHARYNGITIS STREPTOCOCCAL 3 0.0003
313 PRODUCT PRESCRIBING ISSUE 6 0.0003
314 VENTRICULAR ARRHYTHMIA 1 0.0003
315 RESPIRATORY TRACT INFECTION 7 0.0003
316 HYPERACUSIS 1 0.0003
317 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 19 0.0003
318 PRODUCT STORAGE ISSUE 1 0.0003
319 RHINORRHOEA 17 0.0003
320 INSURANCE ISSUE 4 0.0003
321 CLAVICLE FRACTURE 1 0.0003
322 OESOPHAGEAL DISORDER 1 0.0003
323 ATRIOVENTRICULAR BLOCK 2 0.0003
324 LOW DENSITY LIPOPROTEIN INCREASED 2 0.0003
325 EJECTION FRACTION DECREASED 4 0.0003
326 EPIGASTRIC DISCOMFORT 1 0.0003
327 BRAIN FOG 4 0.0003
328 NASAL DISCOMFORT 2 0.0003
329 INFLAMMATION 13 0.0003
330 OESOPHAGEAL CANDIDIASIS 1 0.0003
331 OBSTRUCTION 1 0.0003
332 TRIGGER FINGER 1 0.0002
333 DEMYELINATION 1 0.0002
334 OROPHARYNGEAL PAIN 22 0.0002
335 TONGUE DISCOMFORT 1 0.0002
336 HEPATITIS 6 0.0002
337 INTERVERTEBRAL DISC DISORDER 1 0.0002
338 PRODUCT CONTAINER ISSUE 2 0.0002
339 TENSION HEADACHE 1 0.0002
340 PYELONEPHRITIS 2 0.0002
341 STAPHYLOCOCCAL BACTERAEMIA 1 0.0002
342 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 41 0.0002
343 IMMUNOSUPPRESSION 2 0.0002
344 PURPURA 2 0.0002
345 HEAD DISCOMFORT 4 0.0002
346 CATHETERISATION CARDIAC 1 0.0002
347 THERAPEUTIC PRODUCT EFFECT DECREASED 10 0.0002
348 OROPHARYNGEAL DISCOMFORT 2 0.0002
349 SUSPECTED OFF LABEL USE 1 0.0002
350 INJECTION SITE PAPULE 1 0.0002
351 EYE OPERATION 1 0.0002
352 ARTHRITIS INFECTIVE 1 0.0002
353 THERAPY CESSATION 11 0.0002
354 SARCOIDOSIS 1 0.0002
355 PRE-ECLAMPSIA 1 0.0002
356 EYE INFLAMMATION 2 0.0002
357 SUBCUTANEOUS ABSCESS 1 0.0002
358 STILLBIRTH 1 0.0002
359 ENTEROCOCCAL INFECTION 1 0.0002
360 RASH VESICULAR 1 0.0002
361 COVID-19 36 0.0002
362 HORMONE LEVEL ABNORMAL 1 0.0002
363 VITREOUS FLOATERS 2 0.0002
364 IMMUNODEFICIENCY 3 0.0002
365 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 11 0.0002
366 WEIGHT LOSS POOR 1 0.0002
367 PRODUCT COLOUR ISSUE 1 0.0002
368 INFLUENZA LIKE ILLNESS 16 0.0002
369 MUSCULOSKELETAL CHEST PAIN 3 0.0002
370 BLOOD CHOLESTEROL INCREASED 9 0.0002
371 FOETAL DEATH 1 0.0002
372 POLYARTHRITIS 1 0.0002
373 ABSCESS 3 0.0002
374 ANAL ABSCESS 1 0.0002
375 DECREASED ACTIVITY 2 0.0002
376 MENSTRUATION DELAYED 2 0.0002
377 SKIN LACERATION 2 0.0002
378 TIC 1 0.0002
379 NECK PAIN 10 0.0002
380 HEART RATE IRREGULAR 4 0.0002
381 PERIORBITAL SWELLING 1 0.0002
382 INTENTIONAL DOSE OMISSION 5 0.0002
383 MICTURITION URGENCY 2 0.0002
384 ILLNESS 18 0.0002
385 MYOCARDITIS 2 0.0002
386 MUSCULOSKELETAL DISCOMFORT 3 0.0002
387 HERPES VIRUS INFECTION 1 0.0002
388 BLOOD URIC ACID INCREASED 1 0.0002
389 VASCULITIS 2 0.0002
390 PRODUCT LABEL CONFUSION 1 0.0002
391 DYSPHONIA 10 0.0002
392 CHILLS 20 0.0002
393 NASAL CONGESTION 10 0.0002
394 URINE ODOUR ABNORMAL 1 0.0002
395 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
396 DECREASED INTEREST 1 0.0002
397 BLOOD IRON DECREASED 2 0.0002
398 CARDIAC PACEMAKER INSERTION 1 0.0002
399 DIABETIC KETOACIDOSIS 4 0.0002
400 GASTROENTERITIS VIRAL 3 0.0002
401 GANGRENE 1 0.0002
402 OSTEOMYELITIS 3 0.0002
403 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
404 PLATELET COUNT ABNORMAL 1 0.0002
405 INGUINAL HERNIA 1 0.0002
406 TENSION 1 0.0002
407 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
408 INJECTION SITE EXTRAVASATION 2 0.0002
409 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 1 0.0002
410 CHOLANGITIS 1 0.0002
411 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
412 PHOTOPSIA 1 0.0002
413 THERAPEUTIC RESPONSE UNEXPECTED 7 0.0002
414 THROAT IRRITATION 7 0.0002
415 NODULE 2 0.0002
416 MYALGIA 26 0.0002
417 INCORRECT PRODUCT STORAGE 2 0.0002
418 NASOPHARYNGITIS 28 0.0002
419 TOOTH INFECTION 2 0.0002
420 PRODUCT FORMULATION ISSUE 1 0.0002
421 SINUS DISORDER 3 0.0002
422 CONDITION AGGRAVATED 46 0.0002
423 THERAPEUTIC RESPONSE SHORTENED 5 0.0002
424 EAR INFECTION 4 0.0002
425 CARDIAC FAILURE ACUTE 1 0.0001
426 SKIN MASS 1 0.0001
427 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
428 INCORRECT DOSE ADMINISTERED 34 0.0001
429 BREAST MASS 1 0.0001
430 POSTOPERATIVE WOUND INFECTION 1 0.0001
431 TASTE DISORDER 3 0.0001
432 DISCOMFORT 9 0.0001
433 PRODUCT LABEL ISSUE 1 0.0001
434 PRODUCTIVE COUGH 7 0.0001
435 PRODUCT PREPARATION ERROR 3 0.0001
436 INTERSTITIAL LUNG DISEASE 7 0.0001
437 LARGE INTESTINE POLYP 1 0.0001
438 LARGE INTESTINE PERFORATION 1 0.0001
439 FORMICATION 1 0.0001
440 APHONIA 2 0.0001
441 DUODENAL ULCER 1 0.0001
442 LYMPHADENOPATHY 5 0.0001
443 HAND FRACTURE 1 0.0001
444 HYPERSENSITIVITY 26 0.0001
445 LIVER FUNCTION TEST INCREASED 3 0.0001
446 POOR QUALITY SLEEP 3 0.0001
447 CELLULITIS 7 0.0001
448 PARAESTHESIA ORAL 2 0.0001
449 PANIC REACTION 1 0.0001
450 VISUAL FIELD DEFECT 1 0.0001
451 INFECTION 20 0.0001
452 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
453 FAECES SOFT 1 0.0001
454 ARTHRALGIA 57 0.0001
455 BLINDNESS TRANSIENT 1 0.0001
456 SENSITIVE SKIN 1 0.0001
457 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
458 ARTHROPOD BITE 1 0.0001
459 SUNBURN 1 0.0001
460 GENERAL SYMPTOM 1 0.0001
461 TROPONIN INCREASED 1 0.0001
462 DEVICE PHYSICAL PROPERTY ISSUE 1 0.0001
463 RENAL FAILURE CHRONIC 1 0.0001
464 FOOD ALLERGY 1 0.0001
465 LYMPHOMA 2 0.0001
466 TENDONITIS 2 0.0001
467 COUGH 36 0.0001
468 GASTROINTESTINAL INFLAMMATION 1 0.0001
469 MULTIPLE ALLERGIES 1 0.0001
470 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
471 FURUNCLE 1 0.0001
472 RENAL CYST 1 0.0001
473 TRICUSPID VALVE INCOMPETENCE 1 0.0001
474 CYSTITIS 4 0.0001
475 ATRIAL FLUTTER 1 0.0001
476 TRANSPLANT REJECTION 1 0.0001
477 MIOSIS 1 0.0001
478 PAIN 76 0.0001
479 PRESYNCOPE 3 0.0001
480 BACK DISORDER 2 0.0001
481 POST PROCEDURAL INFECTION 1 0.0001
482 LUNG DISORDER 6 0.0001
483 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
484 EMBOLISM 1 0.0001
485 HYPOAESTHESIA 18 0.0001
486 VIRAL INFECTION 4 0.0001
487 EOSINOPHIL COUNT INCREASED 1 0.0001
488 WHITE BLOOD CELL COUNT DECREASED 13 0.0001
489 URTICARIA 20 0.0001
490 HEMIPARESIS 2 0.0001
491 SINUSITIS 12 0.0001
492 VITAMIN D DECREASED 1 0.0001
493 SKIN ULCER 3 0.0001
494 BLOOD MAGNESIUM DECREASED 1 0.0001
495 CARDIAC MURMUR 1 0.0001
496 HYSTERECTOMY 1 0.0001
497 SKIN SWELLING 1 0.0001
498 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
499 DEVICE USE ISSUE 2 0.0001
500 FATIGUE 89 0.0001
501 NAIL DISORDER 1 0.0001
502 SYRINGE ISSUE 2 0.0001
503 EOSINOPHILIA 2 0.0001
504 BLOOD CALCIUM INCREASED 1 0.0001
505 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
506 FACIAL PAIN 1 0.0001
507 FEAR 3 0.0001
508 DYSPNOEA 63 0.0001
509 THERAPY NON-RESPONDER 5 0.0001
510 HEART RATE INCREASED 11 0.0001
511 TOOTHACHE 2 0.0001
512 LUPUS-LIKE SYNDROME 1 0.0001
513 GASTROINTESTINAL CARCINOMA 1 0.0001
514 C-REACTIVE PROTEIN INCREASED 4 0.0001
515 NEPHROLITHIASIS 5 0.0001
516 PNEUMONIA BACTERIAL 1 0.0001
517 SKIN DISCOLOURATION 5 0.0001
518 ANAPHYLACTIC REACTION 6 0.0001
519 UROSEPSIS 1 0.0001
520 DIVERTICULITIS 3 0.0001
521 INFLUENZA 12 0.0001
522 HEPATIC STEATOSIS 2 0.0001
523 THINKING ABNORMAL 2 0.0001
524 WOUND 3 0.0001
525 NEPHROPATHY 1 0.0001
526 APPENDICITIS 1 0.0001
527 DIARRHOEA HAEMORRHAGIC 1 0.0001
528 PYREXIA 37 0.0001
529 FLANK PAIN 1 0.0001
530 PHOTOPHOBIA 2 0.0001
531 ABORTION INDUCED 1 0.0001
532 PAIN IN JAW 3 0.0001
533 UNEVALUABLE EVENT 8 0.0001
534 SPINAL DISORDER 1 0.0001
535 SPUTUM DISCOLOURED 1 0.0001
536 OCULAR HYPERAEMIA 5 0.0001
537 MUSCULOSKELETAL DISORDER 2 0.0001
538 MIGRAINE 10 0.0001
539 HYPERSOMNIA 3 0.0001
540 RASH ERYTHEMATOUS 5 0.0001
541 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
542 POST PROCEDURAL COMPLICATION 2 0.0001
543 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 21 0.0001
544 ERUCTATION 2 0.0001
545 VITAMIN D DEFICIENCY 1 0.0001
546 ORAL HERPES 2 0.0001
547 INFLAMMATORY BOWEL DISEASE 1 0.0001
548 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
549 LABORATORY TEST ABNORMAL 3 0.0001
550 INABILITY TO AFFORD MEDICATION 1 0.0001
551 UPPER LIMB FRACTURE 2 0.0001
552 FEELING ABNORMAL 24 0.0001
553 RASH 43 0.0001
554 FLUID RETENTION 5 0.0001
555 INJURY ASSOCIATED WITH DEVICE 2 0.0001
556 MALAISE 43 0.0001
557 EAR DISCOMFORT 1 0.0001
558 OFF LABEL USE 85 0.0001
559 VENTRICULAR EXTRASYSTOLES 1 0.0001
560 PULMONARY HYPERTENSION 2 0.0001
561 TENDERNESS 1 0.0001
562 BRONCHITIS 7 0.0001
563 FULL BLOOD COUNT ABNORMAL 1 0.0001
564 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
565 PALPITATIONS 11 0.0001
566 BREAST PAIN 1 0.0001
567 IMPAIRED WORK ABILITY 2 0.0001
568 HEREDITARY ANGIOEDEMA 1 0.0001
569 RASH PRURITIC 5 0.0001
570 SWELLING FACE 6 0.0001
571 MENTAL DISORDER 4 0.0001
572 OESOPHAGITIS 1 0.0001
573 INJECTION SITE NODULE 1 0.0001
574 BACK PAIN 21 0.0001
575 SKIN DISORDER 3 0.0001
576 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
577 MALNUTRITION 1 0.0001
578 SNEEZING 2 0.0001
579 SKIN INFECTION 1 0.0001
580 TYPE 2 DIABETES MELLITUS 3 0.0001
581 ADVERSE DRUG REACTION 8 0.0001
582 EYE INFECTION 1 0.0001
583 REBOUND EFFECT 1 0.0001
584 MITRAL VALVE INCOMPETENCE 1 0.0001
585 SCAB 1 0.0001
586 HAEMATURIA 3 0.0001
587 CHOLECYSTECTOMY 1 0.0001
588 METASTASES TO LUNG 1 0.0001
589 CARDIAC DISORDER 8 0.0001
590 HEART RATE DECREASED 3 0.0001
591 SEXUAL DYSFUNCTION 1 0.0001
592 BLOOD PRESSURE INCREASED 13 0.0001
593 PAIN IN EXTREMITY 25 0.0001
594 SYSTEMIC LUPUS ERYTHEMATOSUS 3 0.0001
595 PERIPHERAL SWELLING 13 0.0001
596 BACTERAEMIA 1 0.0001
597 CATARACT 5 0.0001
598 ACCIDENT 1 0.0001
599 MACULAR DEGENERATION 1 0.0001
600 JOINT SWELLING 10 0.0001
601 PARAESTHESIA 13 0.0001
602 MENTAL IMPAIRMENT 2 0.0001
603 THERAPEUTIC RESPONSE DECREASED 5 0.0001
604 BURSITIS 1 0.0001
605 URINARY TRACT INFECTION 14 0.0001
606 CYTOPENIA 1 0.0001
607 SMALL INTESTINAL OBSTRUCTION 1 0.0001
608 TENDON RUPTURE 1 0.0001
609 SYNCOPE 8 0.0001
610 SECRETION DISCHARGE 1 0.0001
611 DERMATITIS ALLERGIC 1 0.0001
612 COLITIS 3 0.0001
613 GASTROINTESTINAL DISORDER 7 0.0001
614 MYDRIASIS 1 0.0001
615 ALOPECIA 15 0.0001
616 ADVERSE EVENT 7 0.0001
617 IMMUNE SYSTEM DISORDER 1 0.0001
618 PULMONARY CONGESTION 1 0.0001
619 SWELLING 7 0.0001
620 SINUS CONGESTION 1 0.0001
621 THROAT TIGHTNESS 2 0.0001
622 LIMB INJURY 2 0.0001
623 NEUTROPHIL COUNT DECREASED 3 0.0001
624 HEPATIC ENZYME INCREASED 5 0.0001
625 LUNG NEOPLASM MALIGNANT 3 0.0001
626 CORONARY ARTERY OCCLUSION 1 0.0001
627 CONTUSION 7 0.0001
628 TREATMENT FAILURE 6 0.0001
629 DIZZINESS 36 0.0001
630 ARTHROPATHY 4 0.0001
631 MEDICATION ERROR 4 0.0001
632 FEELING COLD 2 0.0001
633 GASTROINTESTINAL HAEMORRHAGE 6 0.0001
634 SEPSIS 8 0.0001
635 HAEMOPTYSIS 2 0.0001
636 MASS 1 0.0001
637 ABDOMINAL DISCOMFORT 12 0.0001
638 CARPAL TUNNEL SYNDROME 1 0.0001
639 BURNING SENSATION 5 0.0001
640 BLINDNESS UNILATERAL 1 0.0001
641 SEASONAL ALLERGY 1 0.0001
642 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
643 CARDIOGENIC SHOCK 1 0.0001
644 ACCIDENTAL UNDERDOSE 1 0.0001
645 MYELODYSPLASTIC SYNDROME 1 0.0001
646 HYPERTHYROIDISM 1 0.0001
647 INJECTION SITE HAEMATOMA 1 0.0001
648 HYPOKINESIA 1 0.0001
649 GASTROENTERITIS 1 0.0001
650 DYSSTASIA 2 0.0001
651 BONE PAIN 4 0.0001
652 CARDIOMYOPATHY 1 0.0001
653 TACHYCARDIA 6 0.0001
654 URINARY INCONTINENCE 2 0.0001
655 PULMONARY OEDEMA 3 0.0001
656 HOT FLUSH 5 0.0001
657 HYPOAESTHESIA ORAL 1 0.0001
658 APHASIA 2 0.0001
659 STOMATITIS 4 0.0001
660 OSTEOPENIA 1 0.0001
661 PLEURAL EFFUSION 4 0.0001
662 HEADACHE 41 0.0001
663 DEVICE RELATED INFECTION 1 0.0001
664 LUNG INFECTION 1 0.0001
665 DRUG-INDUCED LIVER INJURY 2 0.0001
666 NAUSEA 50 0.0001
667 DISEASE RECURRENCE 3 0.0001
668 ULCER 1 0.0001
669 SCIATICA 1 0.0001
670 SENSORY DISTURBANCE 1 0.0001
671 HYPERHIDROSIS 8 0.0001
672 NIGHT SWEATS 2 0.0001
673 ASTHMA 7 0.0001
674 DRY MOUTH 5 0.0001
675 PHOTOSENSITIVITY REACTION 1 0.0001
676 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
677 DRY EYE 3 0.0001
678 LIP SWELLING 2 0.0001
679 LEUKOPENIA 3 0.0001
680 GAIT INABILITY 2 0.0001
681 FACE OEDEMA 1 0.0001
682 CANDIDA INFECTION 1 0.0001
683 SCAR 1 0.0001
684 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
685 DRUG INEFFECTIVE 76 0.0001
686 PRURITUS 22 0.0001
687 PRODUCT STORAGE ERROR 5 0.0001
688 METASTASES TO LIVER 1 0.0001
689 DEPRESSED MOOD 3 0.0001
690 COLD SWEAT 1 0.0001
691 HYPERTENSION 12 0.0001
692 GALLBLADDER DISORDER 1 0.0001
693 THIRST 1 0.0001
694 GOUT 1 0.0001
695 DRUG EFFECT DECREASED 3 0.0001
696 RESTLESS LEGS SYNDROME 1 0.0001
697 BONE DISORDER 1 0.0001
698 PANIC ATTACK 2 0.0001
699 UNDERDOSE 4 0.0001
700 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
701 DRUG DOSE OMISSION 9 0.0001
702 HAEMATOCHEZIA 3 0.0001
703 DYSURIA 2 0.0001
704 BLOOD GLUCOSE ABNORMAL 1 0.0001
705 BREAST CANCER 5 0.0001
706 BLISTER 3 0.0001
707 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
708 EYE PAIN 3 0.0001
709 DYSPNOEA EXERTIONAL 2 0.0001
710 BLOOD SODIUM DECREASED 1 0.0001
711 MUSCULAR WEAKNESS 6 0.0001
712 FOOT FRACTURE 1 0.0001
713 ANXIETY 15 0.0001
714 BLOOD URINE PRESENT 1 0.0001
715 INSOMNIA 14 0.0001
716 FEELING JITTERY 1 0.0001
717 SLEEP APNOEA SYNDROME 1 0.0001
718 HERPES ZOSTER 3 0.0001
719 LETHARGY 3 0.0001
720 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
721 SEROTONIN SYNDROME 1 0.0001
722 ACUTE RESPIRATORY FAILURE 1 0.0001
723 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
724 KIDNEY INFECTION 1 0.0001
725 BLOOD PRESSURE ABNORMAL 1 0.0001
726 SPINAL FRACTURE 1 0.0000
727 PRODUCT PHYSICAL ISSUE 1 0.0000
728 PRODUCT ADMINISTRATION ERROR 1 0.0000
729 EXTRA DOSE ADMINISTERED 2 0.0000
730 BLINDNESS 2 0.0000
731 FEELING HOT 3 0.0000
732 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
733 ERYTHEMA 10 0.0000
734 VISUAL IMPAIRMENT 6 0.0000
735 POLLAKIURIA 2 0.0000
736 ASTHENIA 18 0.0000
737 DECREASED APPETITE 11 0.0000
738 ABDOMINAL PAIN 11 0.0000
739 EATING DISORDER 1 0.0000
740 JOINT INJURY 1 0.0000
741 IRRITABLE BOWEL SYNDROME 1 0.0000
742 HYPOACUSIS 2 0.0000
743 SKIN CANCER 1 0.0000
744 FAECES DISCOLOURED 1 0.0000
745 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
746 ANGIOEDEMA 2 0.0000
747 TOOTH DISORDER 1 0.0000
748 RASH MACULO-PAPULAR 1 0.0000
749 HEPATOTOXICITY 1 0.0000
750 HYPOTENSION 9 0.0000
751 COLITIS ULCERATIVE 2 0.0000
752 RASH PAPULAR 1 0.0000
753 CHROMATURIA 1 0.0000
754 ABDOMINAL PAIN UPPER 9 0.0000
755 MUSCLE SPASMS 8 0.0000
756 MUSCLE TWITCHING 1 0.0000
757 RENAL DISORDER 2 0.0000
758 PRODUCT USE ISSUE 8 0.0000
759 SLEEP DISORDER 3 0.0000
760 ARRHYTHMIA 2 0.0000
761 TREMOR 7 0.0000
762 PRODUCT PRESCRIBING ERROR 1 0.0000
763 DIARRHOEA 27 0.0000
764 HEPATIC CANCER 1 0.0000
765 HYPOGLYCAEMIA 2 0.0000
766 NEURALGIA 1 0.0000
767 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
768 ABDOMINAL PAIN LOWER 1 0.0000
769 CARDIOVASCULAR DISORDER 1 0.0000
770 DRUG RESISTANCE 1 0.0000
771 ANAPHYLACTIC SHOCK 1 0.0000
772 UNRESPONSIVE TO STIMULI 1 0.0000
773 RASH GENERALISED 1 0.0000
774 HAEMATOMA 1 0.0000
775 EXPOSURE VIA SKIN CONTACT 1 0.0000
776 ABDOMINAL DISTENSION 4 0.0000
777 NERVOUSNESS 2 0.0000
778 HAEMORRHAGE 4 0.0000
779 DEAFNESS 1 0.0000
780 SEDATION 1 0.0000
781 JOINT STIFFNESS 1 0.0000
782 GASTRITIS 1 0.0000
783 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
784 DEHYDRATION 5 0.0000
785 MENSTRUATION IRREGULAR 1 0.0000
786 JAUNDICE 1 0.0000
787 DISTURBANCE IN ATTENTION 2 0.0000
788 PALLOR 1 0.0000
789 PNEUMONITIS 1 0.0000
790 MOOD ALTERED 1 0.0000
791 GAIT DISTURBANCE 7 0.0000
792 FALL 12 0.0000
793 DEMENTIA 1 0.0000
794 WEIGHT INCREASED 8 0.0000
795 FLATULENCE 2 0.0000
796 RHEUMATOID ARTHRITIS 4 0.0000
797 ANGINA PECTORIS 1 0.0000
798 EYE IRRITATION 2 0.0000
799 BALANCE DISORDER 3 0.0000
800 SEIZURE 4 0.0000
801 LIVER FUNCTION TEST ABNORMAL 1 0.0000
802 NEEDLE ISSUE 1 0.0000
803 MUSCULOSKELETAL STIFFNESS 3 0.0000
804 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
805 SURGERY 2 0.0000
806 PNEUMONIA 11 0.0000
807 WHEEZING 2 0.0000
808 MATERNAL EXPOSURE DURING PREGNANCY 3 0.0000
809 RESPIRATORY DISORDER 1 0.0000
810 BLOOD POTASSIUM DECREASED 1 0.0000
811 HEPATIC FAILURE 1 0.0000
812 VERTIGO 2 0.0000
813 SUICIDAL IDEATION 3 0.0000
814 ACUTE KIDNEY INJURY 5 0.0000
815 EMOTIONAL DISORDER 1 0.0000
816 LIMB DISCOMFORT 1 0.0000
817 EXPOSURE DURING PREGNANCY 2 0.0000
818 SWOLLEN TONGUE 1 0.0000
819 HEAD INJURY 1 0.0000
820 NEUROPATHY PERIPHERAL 3 0.0000
821 HYPOTHYROIDISM 1 0.0000
822 LOSS OF CONSCIOUSNESS 4 0.0000
823 ATRIAL FIBRILLATION 3 0.0000
824 PRODUCT DOSE OMISSION 2 0.0000
825 BLOOD CREATININE INCREASED 2 0.0000
826 EYE DISORDER 1 0.0000
827 STAPHYLOCOCCAL INFECTION 1 0.0000
828 INFUSION RELATED REACTION 2 0.0000
829 FUNGAL INFECTION 1 0.0000
830 EYE PRURITUS 1 0.0000
831 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
832 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
833 FLUSHING 3 0.0000
834 HAEMOGLOBIN DECREASED 3 0.0000
835 RASH MACULAR 1 0.0000
836 INJURY 2 0.0000
837 HYPOXIA 1 0.0000
838 PLATELET COUNT DECREASED 3 0.0000
839 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
840 THERAPY INTERRUPTED 2 0.0000
841 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
842 NO ADVERSE EVENT 5 0.0000
843 CRYING 1 0.0000
844 HYPERGLYCAEMIA 1 0.0000
845 ACCIDENTAL OVERDOSE 1 0.0000
846 AGITATION 2 0.0000
847 THROMBOCYTOPENIA 3 0.0000
848 EPISTAXIS 2 0.0000
849 ARTHRITIS 2 0.0000
850 DISEASE PROGRESSION 3 0.0000
851 ABNORMAL BEHAVIOUR 1 0.0000
852 DISORIENTATION 1 0.0000
853 DRUG INTERACTION 4 0.0000
854 ABORTION SPONTANEOUS 1 0.0000
855 OEDEMA PERIPHERAL 3 0.0000
856 RENAL IMPAIRMENT 2 0.0000
857 SKIN EXFOLIATION 2 0.0000
858 OSTEOARTHRITIS 1 0.0000
859 VOMITING 11 0.0000
860 VAGINAL HAEMORRHAGE 1 0.0000
861 MYOCARDIAL INFARCTION 4 0.0000
862 LIVER DISORDER 1 0.0000
863 PRODUCT QUALITY ISSUE 3 0.0000
864 COGNITIVE DISORDER 1 0.0000
865 COLORECTAL CANCER 1 0.0000
866 MULTIPLE SCLEROSIS 1 0.0000
867 BLOOD GLUCOSE DECREASED 1 0.0000
868 DYSPEPSIA 2 0.0000
869 SOMNOLENCE 4 0.0000
870 HOSPITALISATION 3 0.0000
871 ECZEMA 1 0.0000
872 MUSCULOSKELETAL PAIN 1 0.0000
873 DERMATITIS ATOPIC 1 0.0000
874 DEATH 16 0.0000
875 TREATMENT NONCOMPLIANCE 1 0.0000
876 PANCYTOPENIA 1 0.0000
877 OXYGEN SATURATION DECREASED 1 0.0000
878 ILL-DEFINED DISORDER 1 0.0000
879 PRODUCT USE IN UNAPPROVED INDICATION 4 0.0000
880 BLOOD GLUCOSE INCREASED 3 0.0000
881 DEEP VEIN THROMBOSIS 1 0.0000
882 DEVICE DIFFICULT TO USE 1 0.0000
883 BLOOD PRESSURE DECREASED 1 0.0000
884 DRY SKIN 2 0.0000
885 NEOPLASM MALIGNANT 1 0.0000
886 NEUTROPENIA 2 0.0000
887 VISION BLURRED 2 0.0000
888 MEMORY IMPAIRMENT 2 0.0000
889 MOBILITY DECREASED 1 0.0000
890 RESPIRATORY FAILURE 1 0.0000
891 DYSGEUSIA 1 0.0000
892 HALLUCINATION 1 0.0000
893 DEPRESSION 3 0.0000
894 CHRONIC KIDNEY DISEASE 1 0.0000
895 CARDIAC FAILURE 1 0.0000
896 PROSTATE CANCER 1 0.0000
897 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
898 CONFUSIONAL STATE 2 0.0000
899 CARDIAC ARREST 1 0.0000
900 DEVICE ISSUE 1 0.0000
901 WEIGHT DECREASED 3 0.0000
902 DYSPHAGIA 1 0.0000
903 PULMONARY EMBOLISM 1 0.0000
904 ANAEMIA 2 0.0000
905 DRUG INTOLERANCE 1 0.0000
906 OVERDOSE 2 0.0000
907 CONSTIPATION 2 0.0000
908 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
909 RENAL FAILURE 1 0.0000